Breaking News Instant updates and real-time market news.

JD

JD.com

$65.70 /

+2.09 (+3.29%)

20:45
08/23/21
08/23
20:45
08/23/21
20:45

JD.com price target lowered to $108 from $115 at Citi

Citi analyst Alicia Yap lowered the firm's price target on JD.com to $108 from $115 but keeps a Buy rating on the shares. The company reported a solid beat quarter with higher user engagement, higher spending, and transaction frequency, the analyst tells investors in a research note. JD.com is facing macro and natural disaster challenges, thanks to JD's strength in supply chain capability and customer service quality, but the management is relatively optimistic on the second half growth outlook, Yap adds.

  • 23

    Aug

  • 27

    Aug

JD JD.com
$65.70 /

+2.09 (+3.29%)

07/27/21 Mizuho
Mizuho says China's education crackdown won't carry over to other sectors
07/27/21 DZ Bank
JD.com downgraded to Sell from Buy at DZ Bank
07/22/21 Mizuho
Baidu should be bought into results, says Mizuho
07/13/21 Arete
JD.com price target lowered to $95 from $100 at Arete

TODAY'S FREE FLY STORIES

Downgrade
OMV AG downgraded to Neutral from Overweight at JPMorgan » 05:15
09/17/21
09/17
05:15
09/17/21
05:15
OMVKY

OMV AG

$59.72 /

-0.65 (-1.08%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMVKY OMV AG
$59.72 /

-0.65 (-1.08%)

OMVKY OMV AG
$59.72 /

-0.65 (-1.08%)

09/16/21 Deutsche Bank
OMV AG price target raised to EUR 55.60 from EUR 50.30 at Deutsche Bank
08/03/21 Societe Generale
OMV AG price target raised to EUR 57 from EUR 55 at Societe Generale
07/30/21 Berenberg
OMV AG downgraded to Hold from Buy at Berenberg
07/29/21 Deutsche Bank
OMV AG price target raised to EUR 50.30 from EUR 48.90 at Deutsche Bank
Downgrade
Galp Energia downgraded to Underweight from Neutral at JPMorgan » 05:14
09/17/21
09/17
05:14
09/17/21
05:14
GLPEY

Galp Energia

$4.92 /

+0.04 (+0.82%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLPEY Galp Energia
$4.92 /

+0.04 (+0.82%)

08/06/21 Morgan Stanley
Galp Energia price target lowered to EUR 10.10 from EUR 10.50 at Morgan Stanley
07/27/21 JPMorgan
Galp Energia price target lowered to EUR 10.50 from EUR 11 at JPMorgan
07/27/21 Societe Generale
Galp Energia upgraded to Buy from Hold at Societe Generale
06/22/21 RBC Capital
Galp Energia downgraded to Sector Perform from Outperform at RBC Capital
Hot Stocks
Dada Nexus announces launch of open digital logistics platform » 05:14
09/17/21
09/17
05:14
09/17/21
05:14
DADA

Dada Nexus

$21.85 /

+ (+0.00%)

Dada Group announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DADA Dada Nexus
$21.85 /

+ (+0.00%)

DADA Dada Nexus
$21.85 /

+ (+0.00%)

09/09/21 KeyBanc
Dada Nexus price target lowered to $40 from $47 at KeyBanc
06/09/21
Fly Intel: Top five analyst initiations
06/09/21 Citi
Dada Nexus price target raised to $37 from $36 at Citi
06/09/21 JPMorgan
Dada Nexus initiated with an Overweight at JPMorgan
DADA Dada Nexus
$21.85 /

+ (+0.00%)

  • 03
    Dec
DADA Dada Nexus
$21.85 /

+ (+0.00%)

Earnings
Biophytis reports 1H EPS (EUR 0.14) vs, (EUR 0.25) last year » 05:11
09/17/21
09/17
05:11
09/17/21
05:11
BPTS

Biophytis

$8.90 /

+0.05 (+0.56%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPTS Biophytis
$8.90 /

+0.05 (+0.56%)

  • 10
    Feb
Initiation
Recordati initiated with an Equal Weight at Barclays » 05:11
09/17/21
09/17
05:11
09/17/21
05:11
RCDTF

Recordati

$57.00 /

+ (+0.00%)

Barclays initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCDTF Recordati
$57.00 /

+ (+0.00%)

RCDTF Recordati
$57.00 /

+ (+0.00%)

07/30/21 Oddo BHF
Recordati downgraded to Underperform from Neutral at Oddo BHF
06/25/21 JPMorgan
Recordati initiated with a Neutral at JPMorgan
06/24/21 JPMorgan
Recordati initiated with a Neutral at JPMorgan
04/20/21 Deutsche Bank
Recordati initiated with a Hold at Deutsche Bank
Upgrade
Standard Chartered upgraded to Equal Weight from Underweight at Barclays » 05:08
09/17/21
09/17
05:08
09/17/21
05:08
SCBFY

Standard Chartered

$12.16 /

-0.025 (-0.21%)

Barclays analyst Aman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCBFY Standard Chartered
$12.16 /

-0.025 (-0.21%)

09/15/21 Exane BNP Paribas
Standard Chartered upgraded to Neutral from Underperform at Exane BNP Paribas
08/11/21 Morgan Stanley
Standard Chartered price target raised to 480 GBp at Morgan Stanley
08/10/21 UBS
Standard Chartered price target lowered to 465 GBp from 490 GBp at UBS
07/07/21 UBS
Standard Chartered price target lowered to 490 GBp from 530 GBp at UBS
Upgrade
HSBC upgraded to Overweight from Underweight at Barclays » 05:07
09/17/21
09/17
05:07
09/17/21
05:07
HSBC

HSBC

$25.49 /

-0.25 (-0.97%)

Barclays analyst Aman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

05:01 Today RBC Capital
HSBC upgraded to Outperform from Sector Perform at RBC Capital
08/09/21 RBC Capital
HSBC price target lowered to 450 GBp from 480 GBp at RBC Capital
08/05/21 Morgan Stanley
HSBC price target raised to 450 GBp from 430 GBp at Morgan Stanley
08/04/21 JPMorgan
HSBC upgraded to Overweight from Neutral at JPMorgan
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

Hot Stocks
Fresenius Medical enters home dialysis distribution deal in Japan with JMS Co. » 05:06
09/17/21
09/17
05:06
09/17/21
05:06
FMS

Fresenius Medical

$35.31 /

-0.36 (-1.01%)

Fresenius Medical Care…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

09/10/21 Barclays
Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
09/10/21 JPMorgan
Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
08/11/21 JPMorgan
Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
08/04/21 Societe Generale
Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

General news
FX Update: USD-JPY has lifted to a three-day high » 05:05
09/17/21
09/17
05:05
09/17/21
05:05
$ECON

Economic Data

/

+

FX Update: USD-JPY has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
Novatek downgraded to Hold from Buy at HSBC » 05:04
09/17/21
09/17
05:04
09/17/21
05:04
NOVKY

Novatek

$260.36 /

-7.9048 (-2.95%)

HSBC analyst Ildar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOVKY Novatek
$260.36 /

-7.9048 (-2.95%)

06/03/21 VTB Capital
Novatek upgraded to Buy from Hold at VTB Capital
01/15/21 JPMorgan
Novatek downgraded to Neutral from Overweight at JPMorgan
12/16/20 Renaissance Capital
Novatek downgraded to Hold from Buy at Renaissance Capital
11/27/20 VTB Capital
Novatek downgraded to Hold from Buy at VTB Capital
Upgrade
HSBC upgraded to Outperform from Sector Perform at RBC Capital » 05:01
09/17/21
09/17
05:01
09/17/21
05:01
HSBC

HSBC

$25.49 /

-0.25 (-0.97%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

08/09/21 RBC Capital
HSBC price target lowered to 450 GBp from 480 GBp at RBC Capital
08/05/21 Morgan Stanley
HSBC price target raised to 450 GBp from 430 GBp at Morgan Stanley
08/04/21 JPMorgan
HSBC upgraded to Overweight from Neutral at JPMorgan
08/03/21 DBS Bank
HSBC upgraded to Buy from Hold at DBS Bank
HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

HSBC HSBC
$25.49 /

-0.25 (-0.97%)

Initiation
Kingspan initiated with an Outperform at Credit Suisse » 04:57
09/17/21
09/17
04:57
09/17/21
04:57
KGSPY

Kingspan

$114.12 /

-1.158 (-1.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KGSPY Kingspan
$114.12 /

-1.158 (-1.00%)

09/07/21 Berenberg
Kingspan price target raised to EUR 110 from EUR 100 at Berenberg
08/26/21 Deutsche Bank
Kingspan price target raised to EUR 94 from EUR 85 at Deutsche Bank
08/23/21 Barclays
Kingspan price target raised to EUR 85 from EUR 75 at Barclays
08/23/21 JPMorgan
Kingspan price target raised to EUR 83 from EUR 76 at JPMorgan
Downgrade
Take-Two downgraded to Market Perform from Outperform at BMO Capital » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
TTWO

Take-Two

$151.89 /

-0.78 (-0.51%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

09/14/21 Ascendiant
Take-Two price target lowered to $198 from $216 at Ascendiant
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

TTWO Take-Two
$151.89 /

-0.78 (-0.51%)

Conference/Events
Leap Therapeutics to host conference call » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
LPTX

Leap Therapeutics

$2.52 /

+0.57 (+29.23%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

09/16/21 Piper Sandler
Leap data show 'very favorable early signal,' says Piper Sandler
09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

LPTX Leap Therapeutics
$2.52 /

+0.57 (+29.23%)

Conference/Events
ChannelAdvisor to hold virtual analyst day » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ECOM

ChannelAdvisor

$26.97 /

-0.12 (-0.44%)

Virtual Analyst Day to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$26.97 /

-0.12 (-0.44%)

ECOM ChannelAdvisor
$26.97 /

-0.12 (-0.44%)

02/12/21 B. Riley Securities
ChannelAdvisor price target raised to $36 from $30 at B. Riley Securities
02/09/21 B. Riley Securities
ChannelAdvisor price target raised to $30 from $24.50 at B. Riley Securities
11/05/20 Baird
ChannelAdvisor price target lowered to $18 from $20 at Baird
10/16/20
Fly Intel: Top five analyst upgrades
ECOM ChannelAdvisor
$26.97 /

-0.12 (-0.44%)

Conference/Events
Truist to hold a virtual bus tour » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
ATVI

Activision Blizzard

$79.31 /

+1.06 (+1.35%)

, EA

Electronic Arts

$135.85 /

-1.21 (-0.88%)

, MGNI

Magnite

$29.48 /

-0.52 (-1.73%)

, PLTK

Playtika

$28.51 /

+0.15 (+0.53%)

, RBLX

Roblox

$81.40 /

-0.725 (-0.88%)

, ROKU

Roku

$323.03 /

+4.41 (+1.38%)

, VZIO

Vizio

$18.33 /

-0.4 (-2.14%)

, ZNGA

Zynga

$7.99 /

-0.045 (-0.56%)

Digital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

PLTK Playtika
$28.51 /

+0.15 (+0.53%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Raymond James
Delay of EA's Battlefield 2042 likely a 'mild negative,' says Raymond James
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
MGNI Magnite
$29.48 /

-0.52 (-1.73%)

09/16/21 Susquehanna
Magnite upbeat analyst reaffirms positive thesis, says Susquehanna
08/31/21 Macquarie
Macquarie starts 'SSP leader' Magnite at Outperform
08/31/21 Macquarie
Magnite initiated with an Outperform at Macquarie
08/09/21 RBC Capital
Magnite assumed with an Outperform at RBC Capital
PLTK Playtika
$28.51 /

+0.15 (+0.53%)

09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
08/05/21 Cowen
Playtika valuation remains extremely attractive, says Cowen
06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
RBLX Roblox
$81.40 /

-0.725 (-0.88%)

09/15/21 Benchmark
Benchmark reiterates Sell rating on Roblox after 'weak' August indicators
09/15/21 Truist
Roblox key performance indicators for August 'solid,' says Truist
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
ROKU Roku
$323.03 /

+4.41 (+1.38%)

09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/09/21 Stephens
Premium prices of Amazon TVs reduces risk for Roku, says Stephens
09/09/21 KeyBanc
New Amazon Fire TVs 'incremental positive' for Roku, says KeyBanc
09/09/21 JPMorgan
Vizio added as new best idea in SMID-cap U.S. Internet at JPMorgan
VZIO Vizio
$18.33 /

-0.4 (-2.14%)

09/14/21
Fly Intel: Top five analyst initiations
09/14/21 Stephens
Stephens starts Vizio at Overweight with $27 price target
09/13/21 Stephens
Vizio initiated with an Overweight at Stephens
09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

PLTK Playtika
$28.51 /

+0.15 (+0.53%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

  • 25
    Mar
  • 15
    Jan
ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

PLTK Playtika
$28.51 /

+0.15 (+0.53%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

ATVI Activision Blizzard
$79.31 /

+1.06 (+1.35%)

EA Electronic Arts
$135.85 /

-1.21 (-0.88%)

MGNI Magnite
$29.48 /

-0.52 (-1.73%)

RBLX Roblox
$81.40 /

-0.725 (-0.88%)

ROKU Roku
$323.03 /

+4.41 (+1.38%)

VZIO Vizio
$18.33 /

-0.4 (-2.14%)

ZNGA Zynga
$7.99 /

-0.045 (-0.56%)

Conference/Events
PJT Partners participates in a conference call with JMP Securities » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
PJT

PJT Partners

$76.77 /

-0.46 (-0.60%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PJT PJT Partners
$76.77 /

-0.46 (-0.60%)

PJT PJT Partners
$76.77 /

-0.46 (-0.60%)

04/08/21 Wolfe Research
PJT Partners downgraded to Peer Perform from Outperform at Wolfe Research
03/25/21 Keefe Bruyette
PJT Partners initiated with an Outperform at Keefe Bruyette
12/16/20 Seaport Global
Seaport Global starts PJT Partners at Buy with $91 price target
12/16/20 Seaport Global
PJT Partners initiated with a Buy at Seaport Global
PJT PJT Partners
$76.77 /

-0.46 (-0.60%)

Conference/Events
Baidu participates in a conference call with Mizuho » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
BIDU

Baidu

$159.54 /

-2.12 (-1.31%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIDU Baidu
$159.54 /

-2.12 (-1.31%)

BIDU Baidu
$159.54 /

-2.12 (-1.31%)

09/06/21 KGI Securities
Baidu initiated with a Neutral at KGI Securities
08/20/21
Fly Intel: Top five analyst downgrades
08/20/21 Erste Group
Baidu downgraded to Sell from Hold at Erste Group
08/18/21 Susquehanna
Baidu price target lowered to $200 from $250 at Susquehanna
BIDU Baidu
$159.54 /

-2.12 (-1.31%)

  • 26
    Mar
BIDU Baidu
$159.54 /

-2.12 (-1.31%)

BIDU Baidu
$159.54 /

-2.12 (-1.31%)

BIDU Baidu
$159.54 /

-2.12 (-1.31%)

Conference/Events
Ambarella management to meet with MKM Partners » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
AMBA

Ambarella

$152.64 /

+0.05 (+0.03%)

Meeting to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

09/02/21 Roth Capital
Ambarella price target raised to $170 from $130 at Roth Capital
09/01/21 Cowen
Ambarella price target raised to $150 from $140 at Cowen
09/01/21 Craig-Hallum
Ambarella price target raised to $170 from $150 at Craig-Hallum
09/01/21 Wells Fargo
Ambarella price target raised to $115 from $110 at Wells Fargo
AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

AMBA Ambarella
$152.64 /

+0.05 (+0.03%)

Conference/Events
MarketWise management to meet virtually with Oppenheimer » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
MKTW

MarketWise

$9.00 /

+0.33 (+3.81%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKTW MarketWise
$9.00 /

+0.33 (+3.81%)

MKTW MarketWise
$9.00 /

+0.33 (+3.81%)

08/31/21 UBS
UBS starts MarketWise with a Buy
08/31/21 UBS
MarketWise initiated with a Buy at UBS
08/19/21 Wedbush
Wedbush bullish on MarketWise, initiates with an Outperform
08/19/21 Wedbush
MarketWise initiated with an Outperform at Wedbush
Conference/Events
TCR2 Therapeutics to host conference call » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
TCRR

TCR2 Therapeutics

$15.71 /

-0.51 (-3.14%)

Management provides an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

08/06/21 BMO Capital
TCR2 Therapeutics price target lowered to $44 from $53 at BMO Capital
06/24/21 Goldman Sachs
TCR2 Therapeutics initiated with a Buy at Goldman Sachs
06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
TCRR TCR2 Therapeutics
$15.71 /

-0.51 (-3.14%)

  • 20
    Jan
Conference/Events
Molina Healthcare to hold a virtual investor day » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
MOH

Molina Healthcare

$270.03 /

+3.94 (+1.48%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

09/09/21 Cowen
Molina Healthcare initiated with an Outperform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
07/30/21 BMO Capital
Molina Healthcare price target raised to $315 from $300 at BMO Capital
07/30/21 Mizuho
Molina Healthcare price target raised to $284 from $273 at Mizuho
MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

MOH Molina Healthcare
$270.03 /

+3.94 (+1.48%)

Conference/Events
Citigroup to hold a virtual conference » 04:55
09/17/21
09/17
04:55
09/17/21
04:55

Small/Mid-Cap &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
BofA to hold a virtual conference » 04:55
09/17/21
09/17
04:55
09/17/21
04:55
RHHBY

Roche

$46.82 /

-0.04 (-0.09%)

, ALLO

Allogene Therapeutics

$24.53 /

-0.42 (-1.68%)

, ATR

AptarGroup

$122.29 /

-2.415 (-1.94%)

, FMS

Fresenius Medical

$35.31 /

-0.36 (-1.01%)

, SNY

Sanofi

$48.20 /

+0.185 (+0.39%)

, WAT

Waters

$399.60 /

-10.23 (-2.50%)

, ALNY

Alnylam

$190.23 /

+2.63 (+1.40%)

, BLUE

Bluebird Bio

$17.67 /

-0.12 (-0.67%)

, AZN

AstraZeneca

$56.60 /

+0.14 (+0.25%)

, EXEL

Exelixis

$20.53 /

+0.04 (+0.20%)

, FOLD

Amicus

$11.09 /

-0.06 (-0.54%)

, PFE

Pfizer

$44.46 /

-0.31 (-0.69%)

, PAHC

Phibro Animal Health

$21.32 /

-0.08 (-0.37%)

, QGEN

Qiagen

$54.15 /

+0.6601 (+1.23%)

, IONS

Ionis Pharmaceuticals

$36.45 /

-0.55 (-1.49%)

Global Healthcare Virtual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

ATR AptarGroup
$122.29 /

-2.415 (-1.94%)

FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

WAT Waters
$399.60 /

-10.23 (-2.50%)

ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

FOLD Amicus
$11.09 /

-0.06 (-0.54%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21 UBS
Roche price target raised to CHF 350 from CHF 345 at UBS
08/02/21 JPMorgan
Roche price target raised to CHF 360 from CHF 310 at JPMorgan
07/27/21 Societe Generale
Roche price target raised to CHF 353 from CHF 340 at Societe Generale
ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

08/06/21 B. Riley
Allogene Therapeutics price target lowered to $40 from $52 at B. Riley
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
08/05/21 Oppenheimer
Allogene Therapeutics price target lowered to $44 from $52 at Oppenheimer
06/21/21 Jefferies
Allogene Therapeutics assumed with a Buy at Jefferies
ATR AptarGroup
$122.29 /

-2.415 (-1.94%)

09/13/21 Baird
AptarGroup price target lowered to $135 from $150 at Baird
08/02/21 William Blair
William Blair downgrades AptarGroup after 'underwhelming quarter'
08/02/21 William Blair
AptarGroup downgraded to Market Perform from Outperform at William Blair
04/19/21 Deutsche Bank
AptarGroup price target raised to $162 from $152 at Deutsche Bank
FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

09/10/21 Barclays
Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
09/10/21 JPMorgan
Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
08/11/21 JPMorgan
Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
08/04/21 Societe Generale
Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
SNY Sanofi
$48.20 /

+0.185 (+0.39%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
WAT Waters
$399.60 /

-10.23 (-2.50%)

08/04/21 SVB Leerink
Waters price target raised to $385 from $370 at SVB Leerink
08/04/21 Baird
Waters price target raised to $360 from $297 at Baird
08/04/21 Citi
Waters price target raised to $400 from $315 at Citi
07/06/21 Evercore ISI
Evercore ISI upgrades Waters to Outperform on turnaround progress
ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

08/27/21 BMO Capital
Alnylam price target raised to $196 from $174 at BMO Capital
08/04/21 Barclays
Alnylam price target raised to $216 from $196 at Barclays
08/04/21 Piper Sandler
Alnylam downgraded to Neutral from Overweight at Piper Sandler
06/30/21 Piper Sandler
Alnylam's zilebesiran has 'best in class' potential, says Piper Sandler
BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

08/10/21
Fly Intel: Top five analyst downgrades
08/10/21 BMO Capital
Bluebird Bio price target lowered to $21 from $29 at BMO Capital
08/10/21 Canaccord
Bluebird Bio downgraded to Hold from Buy at Canaccord
08/10/21 Mizuho
Bluebird Bio price target lowered to $29 from $70 at Mizuho
AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
08/12/21 JPMorgan
AstraZeneca resumed with an Overweight at JPMorgan
08/11/21 Goldman Sachs
FibroGen price target lowered to $16 from $22 at Goldman Sachs
08/09/21 Morgan Stanley
AstraZeneca resumed with an Overweight at Morgan Stanley
EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
FOLD Amicus
$11.09 /

-0.06 (-0.54%)

07/19/21 BTIG
Amicus assumed with a Buy at BTIG
07/09/21 Chardan
Amicus coverage transferred at Chardan
07/01/21 Berenberg
Amicus assumed with a Hold at Berenberg
05/27/21 Needham
Amicus initiated with a Hold at Needham
PFE Pfizer
$44.46 /

-0.31 (-0.69%)

09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
09/13/21 JPMorgan
Pfizer price target raised to $42 from $40 at JPMorgan
PAHC Phibro Animal Health
$21.32 /

-0.08 (-0.37%)

08/04/21 Credit Suisse
Phibro Animal Health assumed with a Neutral at Credit Suisse
07/07/21
Fly Intel: Top five analyst downgrades
07/07/21 Barclays
Phibro Animal Health downgraded to Underweight from Equal Weight at Barclays
QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

07/14/21 Citi
Qiagen price target lowered to $58 from $65 at Citi
07/14/21 Kepler Cheuvreux
Qiagen downgraded to Hold from Buy at Kepler Cheuvreux
06/11/21 Berenberg
Qiagen price target lowered to EUR 54 from EUR 56 at Berenberg
06/03/21 Goldman Sachs
Qiagen initiated with a Neutral at Goldman Sachs
IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

07/15/21 Canaccord
Bicycle Therapeutics price target raised to $40 from $36 at Canaccord
07/14/21 Benchmark
Bicycle deal 'makes little sense' for Ionis, says Benchmark
07/13/21 William Blair
Bicycle collaboration a positive for Ionis, says William Blair
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler
RHHBY Roche
$46.82 /

-0.04 (-0.09%)

ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

ATR AptarGroup
$122.29 /

-2.415 (-1.94%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

WAT Waters
$399.60 /

-10.23 (-2.50%)

ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

FOLD Amicus
$11.09 /

-0.06 (-0.54%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

PAHC Phibro Animal Health
$21.32 /

-0.08 (-0.37%)

QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

RHHBY Roche
$46.82 /

-0.04 (-0.09%)

ALLO Allogene Therapeutics
$24.53 /

-0.42 (-1.68%)

FMS Fresenius Medical
$35.31 /

-0.36 (-1.01%)

SNY Sanofi
$48.20 /

+0.185 (+0.39%)

ALNY Alnylam
$190.23 /

+2.63 (+1.40%)

BLUE Bluebird Bio
$17.67 /

-0.12 (-0.67%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

EXEL Exelixis
$20.53 /

+0.04 (+0.20%)

FOLD Amicus
$11.09 /

-0.06 (-0.54%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

QGEN Qiagen
$54.15 /

+0.6601 (+1.23%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

AZN AstraZeneca
$56.60 /

+0.14 (+0.25%)

PFE Pfizer
$44.46 /

-0.31 (-0.69%)

IONS Ionis Pharmaceuticals
$36.45 /

-0.55 (-1.49%)

Conference/Events
FDA Pediatric Advisory Committee to hold a meeting » 04:55
09/17/21
09/17
04:55
09/17/21
04:55

The Committee discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.